openPR Logo
Press release

Granzyme B Antibody Market to Reach USD 400 Million by 2034, Growing at 10.3% CAGR

06-10-2025 09:37 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Granzyme B Antibody

Granzyme B Antibody

The Granzyme B antibody market is poised for substantial growth, with a current market value estimated at $150 million in 2024. The market is projected to reach approximately $400 million by 2034, driven by increasing investments in immunotherapy and the expanding application of Granzyme B in cancer diagnostics and therapeutics. This represents a robust Compound Annual Growth Rate (CAGR) of 10.3% from 2025 to 2034.

Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Granzyme B Antibody market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Granzyme B Antibody market.

This report is also available in the following languages : Japanese (グランザイムB抗体), Korean (그란자임 B 항체), Chinese (颗粒酶B抗体), French (Anticorps Granzyme B), German (Granzym B Antikörper), and Italian (Anticorpo Granzima B), etc.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/66261

Key Companies:
Abcam plc, Cell Signaling Technology, Inc., Santa Cruz Biotechnology, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Sigma-Aldrich (Merck KGaA), R&D Systems, Inc. (a part of Bio-Techne), Miltenyi Biotec GmbH, Invitrogen (a subsidiary of Thermo Fisher Scientific), BioLegend, Inc., GenScript Biotech Corporation, Novus Biologicals (part of the Discovery Life Sciences), Aglient Technologies, Inc., Abnova Corporation, Promega Corporation

Market Segmentation
By Product Type
Monoclonal Antibodies
Polyclonal Antibodies

By Application
Cancer Research
Immunology
Biomarker Discovery

By End User
Pharmaceutical Companies
Academic Research Institutes
Contract Research Organizations

By Technology
ELISA
Western Blotting
Flow Cytometry

By Distribution Channel
Direct Sales
Online Sales

Explore Full Report here: https://exactitudeconsultancy.com/reports/66261/granzyme-b-antibody-market

If opting for the Global version of Granzyme B Antibody Market; then the below country analysis would be included:

- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=66261

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Granzyme B Antibody market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Granzyme B Antibody market.

Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/66261

Reasons To Buy The Granzyme B Antibody Market Report:

➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Our team is available 24/7 to assist and support our customers through reliable research.

Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.

Other Reports:

https://www.hongkongbusinessreporter.com/article/725732989-passenger-vehicle-supercharger-market-is-expected-to-grow-at-5-27-cagr-from-2024-to-2030-exclusive-report-by-exactitude-consultancy

https://www.minnesotabusinessreporter.com/article/728593105-action-cameras-market-size-to-worth-usd-1-01-billion-by-2030-cagr-of-16-2-exactitude-consultancy

https://www.montserratbusinessnetwork.com/article/730322321-food-emulsifiers-market-is-expected-to-be-valued-at-usd-6-21-billion-by-2033-exactitude-consultancy

https://www.worldadvertisingreport.com/article/731290052-pigment-dispersions-market-is-expected-to-be-valued-at-usd-44-42-billion-by-2033-exactitude-consultancy

https://www.myconsumerproductsguide.com/article/723614926-air-ambulance-market-exhibiting-a-cagr-of-10-5-during-the-forecast-period-exactitude-consultancy

https://www.cookislandsbusinessupdate.com/article/733391400-corrugated-boxes-market-is-expected-to-be-valued-at-usd-226-45-billion-by-2033-exactitude-consultancy

https://smb.bluegrasslive.com/article/Engineering-Plastics-Market-is-expected-to-be-valued-at-USD-20016-billion-by-2033-or-Exactitude-Consultancy?storyId=66c43fcdde91e57068ee2946

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Granzyme B Antibody Market to Reach USD 400 Million by 2034, Growing at 10.3% CAGR here

News-ID: 4058874 • Views:

More Releases from Exactitude Consultancy

Gastric Cancer Market Massive Growth opportunity Ahead
Gastric Cancer Market Massive Growth opportunity Ahead
Introduction Gastric cancer, also known as stomach cancer, remains one of the leading causes of cancer-related mortality worldwide. It typically originates in the lining of the stomach and is strongly associated with risk factors such as Helicobacter pylori (H. pylori) infection, smoking, alcohol consumption, dietary habits, genetic predisposition, and chronic gastritis. While incidence has declined in some Western nations due to improved hygiene and dietary shifts, it continues to pose a
Chronic Myelomonocytic Leukemia (CMML) Market Growth, Applications, Innovations and Business Outlook by 2034
Chronic Myelomonocytic Leukemia (CMML) Market Growth, Applications, Innovations …
Introduction Chronic Myelomonocytic Leukemia (CMML) is a rare hematologic malignancy characterized by features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs). It is defined by persistent monocytosis in the blood, bone marrow dysplasia, and a variable clinical course that may progress to acute myeloid leukemia (AML). CMML primarily affects elderly patients and is associated with symptoms such as fatigue, anemia, bleeding tendencies, infections, and splenomegaly. Due to its rarity, CMML remains
Diffuse Large B-Cell Lymphoma (DLBCL) Market Growth, Trends, Consumer Demand and Key Opportunities
Diffuse Large B-Cell Lymphoma (DLBCL) Market Growth, Trends, Consumer Demand and …
Introduction Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL), accounting for approximately 30-40% of cases globally. It is an aggressive malignancy of B-lymphocytes, typically presenting with rapidly enlarging lymph nodes, fever, weight loss, and night sweats. Despite being a fast-growing cancer, DLBCL is potentially curable in many patients with appropriate therapy. Traditional treatment has centered around R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), which remains
Gastrointestinal Anastomosis Market Set to Witness Significant Growth by 2025-2034
Gastrointestinal Anastomosis Market Set to Witness Significant Growth by 2025-20 …
Introduction Gastrointestinal (GI) anastomosis is a critical surgical procedure involving the connection of two segments of the digestive tract, performed after resections for conditions such as cancer, bowel obstruction, Crohn's disease, ulcerative colitis, and trauma. The procedure can be performed using surgical staplers, sutures, or advanced minimally invasive devices. With gastrointestinal cancers, inflammatory bowel disease (IBD), and obesity on the rise globally, the demand for GI anastomosis procedures is expanding rapidly. Advancements

All 5 Releases


More Releases for Granzym

Granzyme H Antibody Market is expected to reach USD 600 million by 2034
" The Granzyme H antibody market is currently valued at approximately $250 million in 2024, driven by increasing research and development in immunotherapy and advancements in cancer treatment. The market is projected to reach around $600 million by 2034, reflecting a robust growth trajectory influenced by expanding applications in autoimmune diseases and enhanced cancer therapies." Exactitude Consultancy., Ltd. released a research report titled "Granzyme H Antibody Market". This report covers the